ASCI members elected to the National Academy of Medicine, 2018

The ASCI congratulates its members who have been elected to the National Academy of Medicine for 2018. Fourteen members are represented among the 75 regular members elected for 2018 (full list). (Citation information following each member as given by the National Academy of Medicine.)

Richard S. Blumberg, MD (elected to ASCI in 1995)

For multiple seminal, paradigm-changing contributions to our understanding of mucosal immunology and immune development having identified mechanistic alterations central to several diseases, including inflammatory bowel disease, autoimmune disorders, and cancer.

Michael A. Caligiuri, MD (elected to ASCI in 1998)

For the discovery of the stages of human natural killer (NK) cell development, the role of IL-15 in NK survival, and in the pathogenesis of NK leukemia and cutaneous T cell lymphoma.

Michael S. Diamond, MD, PhD (elected to ASCI in 2007)

For research on the molecular basis and immune-mediated control of global infectious disease threats, including Zika, dengue, and chikungunya viruses, and defining critical viral determinants of the immune response that have facilitated the development of countermeasures to prevent their spread.

Susan M. Domchek, MD (elected to ASCI in 2013)

For contributions in the evaluation and management of hereditary breast and ovarian cancer including the introduction of two BRCA1/2 specific drug therapies.

Benjamin Levine Ebert, MD, PhD (elected to ASCI in 2011)

For contributions to understanding the genetics and biology of myeloid malignancies, to the characterization of clonal hematopoiesis, and to elucidating the mechanism of action of thalidomide and its analogs.

Robert M. Friedlander, MD, MA (elected to ASCI in 2006)

For demonstrating the role of caspases in cell-death pathways in neurologic diseases, and for groundbreaking discoveries that have led to the development of novel therapies to improve outcomes for patients suffering from stroke, brain and spinal cord injury, Huntington’s disease, and ALS.

William A. Gahl, MD, PhD (elected to ASCI in 1988)

For contributions that include creating the Undiagnosed Diseases Program within intramural NIH to meld individualized patient care with next-generation sequencing and to provide insights into new mechanisms of disease; spearheading expansion to the national Undiagnosed Diseases Network and the Undiagnosed Disease Network International; and championing the sharing of genetic databases and best practices.

David Allen Hafler, MD, MSc (elected to ASCI in 1993)

For seminal discoveries defining the pathogenesis of multiple sclerosis (MS), including identification of autoreactive T cells and mechanisms that underlie their dysregulation, and the discovery of susceptibility genes that lead to MS.

Steven M. Holland, MD (elected to ASCI in 2003)

For distinguished achievements in primary immunodeficiencies and infectious diseases, including the recognition, treatment, genomic identification, and cure of previously unexplained diseases as well as the identification and characterization of novel pathogens in those diseases.

Ophir David Klein, MD, PhD (elected to ASCI in 2013)

For his international reputation in developmental and stem cell biology, focusing on craniofacial, tooth, and bone development and regeneration, destined to lead to the biologically inspired restoration of teeth and other organs.

Matthew Langer Meyerson, MD, PhD (elected to ASCI in 2007)

For discovery of EGFR mutations in lung cancer and their ability to predict responsiveness to EGFR inhibitors, thereby helping to establish the current paradigm of precision cancer therapy.

Lucila Ohno-Machado, MD, PhD (elected to ASCI in 2010)

For creating an algorithm that allows sharing access to clinical data while respecting the privacy of individuals and institutions.

Jordan Scott Orange, MD, PhD (elected to ASCI in 2010)

For his research achievements in defining a new class of immune diseases, natural killer cell deficiencies, as well as other genetic immunodeficiencies.

Rachel M. Werner, MD, PhD (elected to ASCI in 2012)

For advancing our understanding of how health care provider performance measurement and incentives often bring unintended and undesired equity consequences that compete with efficiency goals.

Thank you to recent donors

Visionary Innovator Advocate Benefactor Friend
$10,000 or more $5,000 or more $2,500 or more $2,500 or more up to $1,500
2017 annual appeal Korsmeyer Award Fund Seldin-Smith Award Fund Medical Fellows Initiative
Anupam Agarwal, MD Friend
David H. Alpers, MD Friend
Scott A. Armstrong, MD, PhD Friend
Andrew Arnold, MD Friend
Peter S. Aronson, MD Friend
Richard Aster, MD Friend
John P. Atkinson, MD Benefactor
Barbara J. Ballermann, MD Friend
Robert H. Baloh, MD, PhD Friend
Craig Blackstone, MD, PhD Friend
Paul Laszlo Bollyky, MD, PhD Friend
Myles Brown and Judy Garber Friend Friend
Charles C. J. Carpenter, MD Friend
Jean-Laurent Casanova, MD, PhD Friend
Lynda Chin, MD Friend
Barry S. Coller, MD Friend
Peter Crawford Friend
James E. Crowe, Jr., MD Friend
Darling Foundation Benefactor
John H. Dirks, MD Friend
Ronny I. Drapkin, MD, PhD Friend
David Drutz, MD Friend
Benjamin L. Ebert, MD, PhD Friend
Norman H. Edelman, MD Friend
Jonathan A. Epstein, MD Advocate
James A. Fagin, MD Friend
Anthony W. Ferrante, Jr., MD, PhD Friend
Andrew P. Fontenot, MD Friend
Donald E. Ganem, MD Friend
David Ginsburg, MD Friend
William B. Greenough, III, MD Friend
Karen Guth Friend
Harrington Discovery Institute Visionary
John B. Hawley Friend
Helen H. Hobbs, MD Innovator
David Hockenbery, MD Advocate
Maya Hoptman Friend
Henry N. Hulter, MD Friend
Benjamin D. Humphreys, MD, PhD Friend Friend Friend
Mukesh K. Jain, MD, FAHA Friend
Stuart Kornfeld, MD Friend
Susan Korsmeyer, Carnell Korsmeyer, and John B. Hawley Visionary
Mitchell A. Lazar, MD, PhD Friend
Brendan and Maria Lee Friend
James Lee, MD Friend
Timothy J. Ley, MD Friend
Robert W. Mahley, MD, PhD Friend
Kieren Marr, MD Friend
Donna M. Martin, MD, PhD Friend
Laura Mauri, MD, MSc Friend
Colleen McGarry Friend
Hidayatullah G. Munshi, MD Friend
David G. Nathan, MD Friend
Paul Nghiem, MD, PhD Friend
Peter A. Nigrovic, MD Friend
Scott André Oakes, MD Friend
Robert K. Ockner, MD Friend
John Erik Pandolfino, MD, MSCI Friend
Jane R. Parnes, MD Friend
Daniel Porte, Jr., MD Friend
Louis J. Ptáček, MD Friend
W. Kimryn Rathmell, MD, PhD Friend
Charles W. M. Roberts, MD Friend
Eileen Rojas Friend
Steven M. Rowe, MD, MSPH Friend
Sanjay Saint, MD, MPH Friend Friend
Charles L. Sawyers, MD Visionary
Victor L. Schuster, MD Friend
Debra A. Schwinn, MD Friend
Donald W. Seldin, MD Friend
Dolores M. Shoback, MD Friend
Gerald I. Shulman, MD, PhD Friend
Aisha Siebert Friend
Ben Z. Stanger, MD, PhD Friend
Simeon Taylor, MD, PhD Friend
University of Pittsburgh Friend
Lorraine B. Ware, MD Friend
Arthur Weiss, MD, PhD Friend
Michael A. Weiss, MD, PhD Friend
Michael J. Welsh, MD Friend
Motoko Yanagita, MD, PhD Friend

Call for nominations, 2019 Seldin~Smith Award

The ASCI is pleased to call for nominations for the 2019 Donald Seldin~Holly Smith Award for Pioneering Research. The Award seeks to recognize and connect the next generation of physician-scientist leaders with the legacies of two of the ASCI’s most esteemed members, Drs. Donald W. Seldin and Lloyd H. “Holly” Smith Jr.

For the Award, the ASCI seeks nominations of outstanding physician-scientists who have demonstrated exceptional creativity and accomplishments in biomedical research. The ideal nominee:

  • is an early-stage, clinically active physician-scientist addressing fundamental questions that relate to human health and disease, and
  • shows great promise in biomedicine.

The recipient of the Seldin~Smith Award will receive an unrestricted grant of $30,000 to advance academic efforts. S/he will be recognized at the 2019 AAP/ASCI/APSA Joint Meeting, deliver a research talk at the 2020 Joint Meeting, and receive mentoring from the members of the Seldin~Smith Award Selection Committee and Advisory Committee.

Eligibility

  • MD (or the equivalent) or MD/PhD;
  • The candidate should be more than 2 years but not more than 6 years from first faculty (or the equivalent) appointment at the time of acceptance in April 2019;
  • The candidate spends substantial time in research while providing direct patient care.

This competition is not restricted to any geographic location.

Application

Physician-scientists should apply directly by sending nominations by email attachments to staff@the-asci.org.

  • Completed nomination form, including:
    • a summary of the nominee’s research (not to exceed 100 words)
    • a description of the nominee’s most significant achievement (not to exceed 500 words).
    • a list of the nominee’s three most significant publications and a short statement describing the significance of each publication (not to exceed 100 words each).
    • Nominee’s agreement, if chosen as the recipient, to attend the 2019 AAP/ASCI/APSA Joint Meeting (April 5-7) and the 2020 AAP/ASCI/APSA Joint Meeting (April 3-5).
  • PDFs of the nominee’s three most significant publications as listed in the nomination form.
  • Nominee’s curriculum vitae. Include only educational background, major awards, and peer-reviewed publications (do not include abstracts, grants, or meeting presentations).
  • No more than two letters of support (as PDFs), one from the nominee’s primary mentor, the other ideally from an individual who is a recognized expert on the subject of the nominee’s research.

Notable dates and selection process

  • Nomination deadline: October 29, 2018.
  • Recipient will be notified by early 2019.
  • Recipient will be recognized at the 2019 AAP/ASCI/APSA Joint Meeting, April 5-7.
  • Recipient will deliver a research talk at the 2020 AAP/ASCI/APSA Joint Meeting, April 3-5.

The Seldin~Smith Award Selection Committee reviews nominations and selects finalists for further consideration. Finalists are reviewed by the Seldin~Smith Award Advisory Committee.

About the ASCI

Founded in 1908, the ASCI is home to physician-scientist leaders in academic medicine and industry across the world. The ASCI seeks to support the scientific efforts, educational needs, and clinical aspirations of physician-scientists to improve human health. The Society, based in the United States, is a nonprofit 501(c)(3) organization.

Call for nominations, 2019 Stanley J. Korsmeyer Award

Nominations for the ASCI’s 2019 Stanley J. Korsmeyer Award are now open. The recognition, first called the ASCI Award, was renamed in 2006 in honor of Dr. Korsmeyer, the first recipient of the Award in 1998, who passed away in 2005. The Korsmeyer Award recognizes individuals for their advancement of knowledge in a specific field and mentoring of future generations of life science researchers. Information on all past honorees is available here.

Nominees for the Stanley J. Korsmeyer Award must be ASCI members who are 55 years of age or younger as of January 1, 2019. They shall have made significant contributions to biomedical science and shall have adhered to the principles of scientific excellence that the ASCI exemplifies. The nominee should have a record that reflects high standards of intellectual integrity, a deep and abiding respect for the community of biomedical scientists, and a strong commitment to mentoring the next generation of physician-scientists. Prior nominees may be re-nominated. However, current ASCI Council members and prior Award recipients may not be nominated.

Nominations consist of:

  • a summary of the nominee’s accomplishments (in plain text, not to exceed 250 words),
  • a brief NIH biosketch (as a PDF),
  • a full curriculum vitae, including all publications and invited lectures (as a PDF),
  • and a trainee table (preferred as a PDF).

Nominations must be submitted by ASCI members through their online accounts.

The deadline for nominations is October 11, 2018, at 11:59 PM Eastern (extended from October 8).

Call for applications, JCI Insight Editor, 2019-2024

The American Society for Clinical Investigation (ASCI) seeks an Editor in Chief to lead JCI Insight. The journal was launched in 2016 to support the ASCI’s mission of publishing impactful biomedical research, along with the Journal of Clinical Investigation (JCI).

About the Journal

JCI Insight is a peer-reviewed journal dedicated to the publication of research in all biomedical specialties, ranging from preclinical to clinical studies. While JCI Insight is complementary to the JCI, and both journals are governed by ASCI policies, the Editors and their boards are independent. JCI Insight draws submissions directly and considers submissions previously evaluated by the JCI and other journals. The journal, which the ASCI self-publishes along with the JCI, is online only and freely available to all readers and is supported by publication fees.

Duties of the Editor

The Editor is responsible for: determining the scientific content of JCI Insight; ensuring the quality and integrity of publications; assembling and leading an editorial board to handle research submissions; and meeting goals set by the ASCI Council and Publications Committee.

The selected candidate will have responsibilities that include service on the Council. The term of office is 5 years and begins September 2019.

Eligibility of the Editor and Editorial Board

To be considered for the position of Editor, a candidate must:

  • be a member of the ASCI
  • demonstrate a strong scientific track record

For the proposed Editorial Board:

  • At least two-thirds of the proposed board must be ASCI members (active or senior) in good standing
  • Multi-institution applications are encouraged

Application timeline

  • October 31, 2018: Letters of intent (LOI) due. Applicants submitting LOI will receive an operational overview of the ASCI and JCI Insight for use in developing full applications.
  • January 10, 2019: Full applications due.
  • March 4, 2019: Finalists for the Editor position determined.
  • April 4, 2019: Editor Selection Committee interviews finalists in Chicago.

Full application requirements

The applicant should address the following areas in 5 or fewer single-spaced pages:

  • Describe your vision for the scientific scope of manuscripts published in the journal under your leadership, including scientific areas you see as priorities for JCI Insight and areas you see as opportunities for growth.
  • Provide details of any proposed editorial board members. Describe how you will ensure that the team has the breadth to handle submissions across all specialties and ranging from basic research to clinical trials and bioinformatics.
  • Describe how the proposed board will evaluate manuscripts and specific efforts to ensure scientific rigor, fair decisions, and timeliness. Additionally, comment on the criteria your board will use to select suitable articles to invite for transfer from the JCI to JCI Insight.
  • Describe how you will ensure that JCI Insight complements rather than competes with the JCI in the ASCI family of journals.
  • In the event that you cannot complete the duration of the term, describe the process by which a candidate to replace the Editor would be identified (subject to approval by the Council and a vote by the membership).

In addition, the application must include a letter from each proposed Board member stating a commitment to the role.

Submitting letters of intent and applications

Address materials to Kieren Marr, MD, Chair, Editor Selection Committee, and send as an attachment to staff@the-asci.org.

Questions

Contact Sarah Jackson, Executive Editor, at sarah.jackson@insight.jci.org.

Review of applications

An Editor Selection Committee will review applications, interview candidates, and recommend a selection to the ASCI Council, which then submits the recommendation to a vote of the Active segment of the ASCI membership.

Editor Selection Committee

Chair

Kieren Marr, MD
Johns Hopkins University School of Medicine

Members

Rexford S. Ahima, MD, PhD
Johns Hopkins University School of Medicine

Hossein Ardehali, MD, PhD
Northwestern University Feinberg School of Medicine

Serpil C. Erzurum, MD
Cleveland Clinic

Andrew P. Fontenot, MD
University of Colorado School of Medicine

Sarah Jackson, PhD (non-voting)
Executive Editor

Chaim Putterman, MD
Albert Einstein College of Medicine of Yeshiva University

W. Kimryn Rathmell, MD, PhD
Vanderbilt University School of Medicine

Howard A. Rockman, MD
Duke University School of Medicine

Vijay Shah, MD
Mayo Clinic

Lorraine B. Ware, MD
Vanderbilt University School of Medicine

Nominations for 2019 membership

Nominations for 2019 membership may be submitted through September 10, 2018. Proposers and supporters of nominations should review the Membership Nomination Guide carefully. Questions regarding nominations should be sent by email to staff@the-asci.org.

Note to submitters: The ASCI sends acknowledgment of submissions by email after they have been reviewed and found to be complete. Submitters can check the status of their submissions (nominations and support forms) online by accessing their member accounts.

Submitting nominations

To ensure proper tracking of nominations, all information and documents must be supplied online.
  • First, access your member account
  • After you have logged in to your account, select the “Nominations” tab, then search the nominee database. Links will appear in search results to guide you in the next steps.
  • Your nominee may already be in the ASCI database because the nominee was previously nominated or because a nomination or support form has been started for the nominee for this nomination cycle.

Proposers: Once you have supplied the requested information about your nominee (name, contact information, etc.), you will be able to upload required documents. You will also be able to add Seconder and General Supporter information to the nomination, although supporters will need to supply their comments via their own member accounts.

Seconder and General Supporters: Forms may be drafted and submitted online after selecting the applicable nominee from search results or after adding requested information about the nominee you are supporting. (NOTE: General Supporters who are not ASCI members may complete the nomination support template and email it to staff@the-asci.org for handling. Please indicate clearly your contact information and the name and institution of the nominee you are supporting.)

Further clarification

  • Age criterion for Active and Foreign Associate nominees. Nominees in these categories must be age 50 or younger as of January 1, 2019.
  • Exceptions to the age criterion cannot be made. Although the ASCI Council understands that a nominee’s progress may have been delayed because of unavoidable or extreme circumstances, the Council has on multiple occasions discussed exceptions and concluded from each discussion that no policy could be implemented fairly and durably.
  • Limit on number of nominations per nominee. The number of nominations per nominee is limited to 3, provided the nominee is age 50 as of January 1, 2019.
  • Limit on number of nominations proposed, seconded, or supported. There is no limit to the number of nominations a member may propose or support (either as Seconder or General Supporter).
  • Ph.D.-only candidates. Active and Foreign Associate nominations are, per the ASCI’s bylaws, restricted to physicians.
  • M.D.-equivalent candidates are eligible for nomination.
  • Faculty appointment versus nominee’s country of residence. The distinction between Active and Foreign Associate nominations is made on the basis of residence, not faculty appointment. Active nominees must reside in the U.S. or Canada. Candidates residing elsewhere should be nominated in the Foreign Associate category.

Rexford S. Ahima elected as JCI Editor in Chief

The ASCI is pleased to announce the election of Rexford S. Ahima, MD, PhD, to Editor in Chief of the Journal of Clinical Investigation, effective July 1. He will succeed Gordon Tomaselli, MD, who will become Dean of the Albert Einstein College of Medicine as of July 1. Dr. Ahima has served as a JCI Deputy Editor since July 2017, and he previously served as JCI Associate Editor from 2010 to 2012.

Dr. Ahima

Dr. Ahima, who will be the JCI’s 25th Editor in Chief since its founding in 1924, is Director of the Division of Endocrinology, Diabetes, and Metabolism; Professor of Medicine, Public Health, and Nursing; and Bloomberg Distinguished Professor of Diabetes at Johns Hopkins University. His research focuses on central and peripheral actions of adipocyte hormones in energy homeostasis, and glucose and lipid metabolism. Dr. Ahima is a member of the ASCI (elected 2005) and the Association of American Physicians (elected 2010), as well as a fellow of the American Association for the Advancement of Science.

The Johns Hopkins University-based Editorial Board will continue its stewardship of the JCI. Dr. Tomaselli will become a Deputy Editor, joining Arturo Casadevall, MD, PhD, and Gregg L. Semenza, MD, PhD.

The ASCI recently distributed ballots to Active members recommending Dr. Ahima’s election; nearly 52% of ballots were returned by the June 19 deadline, and voters were overwhelmingly positive about the recommendation. The ASCI’s Secretary-Treasurer, Hossein Ardehali, MD, PhD, oversaw the ballot audit; auditors were Benjamin D. Humphreys, MD, PhD (ASCI Secretary-Treasurer Elect) and Ajay Chawla, MD, PhD.

A tribute to Lloyd H. (“Holly”) Smith Jr., MD

Lloyd Hollingsworth (“Holly”) Smith Jr., MD, passed away on June 18. He was 94.

Elected to the ASCI in 1961, Dr. Smith served as a Councilor from 1966 to 1969 and was the 1969-1970 President. From 1964 to 1985, he served as Chair of the Department of Medicine at the University of California, San Francisco, leading the institution to world-class status in part through a steadfast commitment to incorporating basic-science training in the medical curriculum.

He served on the U.S. President’s Science Advisory Committee from 1970 to 1973 and Harvard University’s Board of Overseers from 1974 to 1980. From 1974 to 1995, he was a member of the Howard Hughes Medical Institute’s Medical Advisory Board, with the last half of his tenure as Board Chair.

We mourn the loss of an ardent supporter of physician-scientists and a true gentleman scholar, whose commitment will not be forgotten.

In his May 4, 1970, Presidential Address, “Biomedical Research and National Policy,” Dr. Smith first remarked upon delivery of the Address itself: “… casual perusal of the past fails to reveal any firm mandate transmitted from a grateful membership for this form of gratuitous pontification. Nevertheless, like some aging Beefeater at the Tower of London, each president bows to history and clings to these atavistic trappings.”

Of course, Dr. Smith’s concerns regarding the broad condition of academic medicine were far from gratuitous, and his eloquent phrasing about challenges to biomedical research and the erosion of support in play at the time — nearly 50 years ago — could be presented today with little revision required:

“There are no easy answers. We have a very broad audience in this country. The basic problem is to convert this audience to a supporting constituency. It will require clarification of our goals, education of the American public, and intimate knowledge of the mechanisms by which decisions are made in the federal government. Some of this can be accomplished individually through education of our friends, patients, colleagues, and our representatives in government. The latter is of particular importance and preferably carried out locally, for the receptivity of the individual congressman increases in a linear fashion as he returns to his constituency. Arguments which appear to be special pleading in Washington gain credence when encountered with specific details in a familiar setting. In addition, there are things which we must do collectively as members of a scientific community.”

In 2014, the ASCI honored Dr. Smith through the creation of the Donald Seldin~Holly Smith Award for Pioneering Research, connecting the legacies of these exemplary leaders in academic medicine with outstanding early-career physician-scientists.

In remembrance of Dr. Smith, we have compiled a collection of photographs; full video from a reception held at the Gladstone Institutes in 2014 recognizing the founding of the Seldin~Smith Award; and an excerpt from his “Conversations with Giants in Medicine” video interview with the Journal of Clinical Investigation.

Our condolences go to Dr. Smith’s wife Margaret, to his family (which he referred to as his “biomass”), and to his many colleagues, trainees, and friends.

With the passing of Dr. Smith and, in late April, of Dr. Seldin, our community has lost two luminaries, both guiding forces and transformational figures for their respective institutions and for the progress of science in medicine writ large.


Kieren Marr, MD
2018-2019 President
On behalf of the ASCI Council


Mukesh K. Jain, MD
2014-2015 President
Chair, Seldin~Smith Award Selection Committee

Memorial contributions to the Seldin~Smith Award

Drs. Kieren Marr and Mukesh Jain recently marked the loss of Donald W. Seldin, MD, a physician-scientist giant, with a tribute to his career and ASCI service, including a photo and video collection. This week, I’m writing to highlight the Society’s recognition of Dr. Seldin through the Donald Seldin~Holly Smith Award for Pioneering Research.

The annual Award, which was conceived in 2015, has so far recognized and supported the careers of four early-career physician-scientists:

  • Christian P. Schaaf, MD, PhD (inaugural recipient, 2016). He is Professor, Clinical Genomics, University of Cologne, Germany, and Visiting Professor, Baylor College of Medicine.
  • Omar I. Abdel-Wahab, MD (2017). He is an Assistant Member in the Human Oncology and Pathogenesis Program (HOPP) and an Attending Physician on the Leukemia Service in the Department of Medicine at Memorial Sloan Kettering Cancer Center.
  • Anna Greka, MD, PhD (co-recipient, 2018). She is Assistant Professor at Harvard Medical School; Institute Member at the Broad Institute of MIT and Harvard; and an Associate Physician at Brigham and Women’s Hospital.
  • Deepak Nijhawan, MD, PhD (co-recipient, 2018). He is Assistant Professor in the Departments of Biochemistry and Hematology and Oncology at UT Southwestern Medical Center.

More information about all Award recipients is available here.

As the ASCI was bringing the Award to fruition, we were heartened by generous contributions from colleagues, friends, and trainees of Drs. Seldin and Smith to support development of the Award. Together, these contributions totaled nearly $500,000. In order to reach an endowment level for the Award, we hope ultimately to reach at least $750,000. This will allow us to support young physician-scientists on exemplary career paths and to honor the outstanding legacies of Drs. Seldin and Smith well into the future.

I hope that as you reflect on Dr. Seldin’s support of physician-scientists and the ASCI, you will consider a contribution in his memory. We will highlight all memorial contributions on the ASCI’s homepage over the coming months, to recognize fully each donor’s generosity and commitment to the physician-scientist community, and to continue honoring a true legend.

Contribute to the Seldin~Smith Award Fund online or by mail

Please contact me with any questions. Thank you, as ever, for your consideration and time.

Sincerely,

John B. Hawley, Executive Director
The American Society for Clinical Investigation

[insert page=’2018-seldin-smith-award-donors’ display=’content’]

A tribute to Donald W. Seldin, MD

We are saddened by the passing of Donald W. Seldin, MD, on April 25 at age 97.

Dr. Seldin was an iconic figure in medicine and the very embodiment of what the ASCI represents. His dedication to the ASCI community rose to the level of legend. Since his election to the Society in 1960, he attended the annual meeting nearly without fail. He served as Councilor from 1961 to 1965, after which he was elected 1965-1966 President.

In his May 2, 1966, Presidential Address, “Some Reflections on the Role of Basic Research and Service in Clinical Departments,” Dr. Seldin noted,

“Investigation is by definition the search for truth, the discovery of new knowledge, the development of explanatory and predictive theories. If this were all, a University would be no different from a research institute. Clearly the University has the vital additional function of education. If investigation is progressively separated from clinical work and teaching, the educational process deteriorates. Only the investigator can inculcate the methods of critical inquiry acquired in research into the routine practice of medicine. Only he can bring physiology and biochemistry meaningfully to bear in the study and treatment of the sick.”

His comments came 14 years into his tenure as Chair of the UT Southwestern Department of Internal Medicine, a position he would hold for another 22 years until 1988. He had begun his UT Southwestern career in 1951, and for a time he was the lone person in the Department, within a medical school sited in a former Army barracks. From this inauspicious foundation, Dr. Seldin transformed UT Southwestern into one of the great institutions worldwide built by physician-scientist powerhouses.

In recent years, the ASCI honored Dr. Seldin and his contributions to the physician-scientist community by creating the Donald W. Seldin~Holly Smith Award for Pioneering Research. The Award connects the careers of these two physician-scientist luminaries with outstanding early-career physician-scientists, and we were fortunate that Dr. Seldin, along with his wife Dr. Ellen Taylor Seldin, was able to attend recent AAP/ASCI/APSA Joint Meetings to celebrate the next generation that the Seldin~Smith Award represents.

We’ve compiled a collection of photographs featuring Dr. Seldin and a video excerpt from his interview in the Journal of Clinical Investigation series “Conversations with Giants in Medicine.” While he leaves a legacy of tremendous accomplishments, he will also be remembered for his sharp wit.

With Dr. Seldin’s passing, his mantle of integrity, intellect, and dedication to academic medicine and the aspiring physician-scientist becomes all of ours to pick up and carry forward.

Kieren Marr, MD
2018-2019 President
On behalf of the ASCI Council

Mukesh K. Jain, MD
2014-2015 President
Chair, Seldin~Smith Award Selection Committee